Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 178
10
Diseases
11
Unique genes
0.338
Avg. similarity score
Familial multiple nevi flammei
Most-connected disease (8 links)
Disease
Searched: Sturge-weber syndrome
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Sturge-weber syndrome
Familial multiple nevi flammei
Hemangioma of choroid
Melanocytoma of the eyeball
Sturge-weber syndrome, somatic, mosaic
Blood vessel neoplasm
Conjunctival nevus
Malignant myoepithelioma
Port-wine stain
Neurodevelopmental disorder with hypotonia and dysmorphic facies
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Familial multiple nevi flammei | 8 | 8 | 1 |
| Hemangioma of choroid | 8 | 8 | 1 |
| Melanocytoma of the eyeball | 8 | 8 | 1 |
| Sturge-weber syndrome | 8 | 8 | 1 |
| Sturge-weber syndrome, somatic, mosaic | 5 | 5 | 2 |
| Blood vessel neoplasm | 4 | 4 | 5 |
| Conjunctival nevus | 4 | 4 | 3 |
| Malignant myoepithelioma | 4 | 4 | 3 |
| Port-wine stain | 4 | 4 | 2 |
| Neurodevelopmental disorder with hypotonia and dysmorphic facies | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| GNAQ | 9 / 10 | Blood vessel neoplasm, Conjunctival nevus, Familial multiple nevi flammei, Hemangioma of choroid and 5 more |
| GNB2 | 2 / 10 | Neurodevelopmental disorder with hypotonia and dysmorphic facies, Sturge-weber syndrome, somatic, mosaic |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Hepatocellular carcinoma | KEGG | 5 / 170 | 32.1× | 2.31e-7 | 1.17e-5 ✓ sig. |
| Melanoma | KEGG | 4 / 73 | 59.8× | 4.01e-7 | 1.89e-5 ✓ sig. |
| Non-small cell lung cancer | KEGG | 4 / 73 | 59.8× | 4.01e-7 | 1.89e-5 ✓ sig. |
| Chemokine signaling pathway | KEGG | 5 / 193 | 28.3× | 4.35e-7 | 2.02e-5 ✓ sig. |
| Glioma | KEGG | 4 / 76 | 57.5× | 4.72e-7 | 2.18e-5 ✓ sig. |
| Chronic myeloid leukemia | KEGG | 4 / 77 | 56.7× | 4.98e-7 | 2.28e-5 ✓ sig. |
| Human cytomegalovirus infection | KEGG | 5 / 226 | 24.2× | 9.51e-7 | 4.00e-5 ✓ sig. |
| Endocrine resistance | KEGG | 4 / 99 | 44.1× | 1.37e-6 | 5.49e-5 ✓ sig. |
| Downstream signal transduction | Reactome | 3 / 29 | 113× | 2.06e-6 | 7.76e-5 ✓ sig. |
| Cholinergic synapse | KEGG | 4 / 115 | 38.0× | 2.50e-6 | 9.13e-5 ✓ sig. |
| Serotonergic synapse | KEGG | 4 / 115 | 38.0× | 2.50e-6 | 9.13e-5 ✓ sig. |
| Pathways in cancer | KEGG | 6 / 533 | 12.3× | 2.84e-6 | 1.02e-4 ✓ sig. |
| Bladder cancer | KEGG | 3 / 41 | 79.9× | 5.98e-6 | 1.91e-4 ✓ sig. |
| Endometrial cancer | KEGG | 3 / 59 | 55.5× | 1.81e-5 | 4.79e-4 ✓ sig. |
| Long-term depression | KEGG | 3 / 60 | 54.6× | 1.90e-5 | 5.00e-4 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| autosome genomic imprinting | GO:0141068 | 2 / 6 | 566× | 4.72e-6 | 3.03e-4 ✓ sig. |
| negative regulation of cell-matrix adhesion | GO:0001953 | 2 / 22 | 154× | 7.23e-5 | 2.43e-3 ✓ sig. |
| negative regulation of neuron apoptotic process | GO:0043524 | 3 / 160 | 31.9× | 9.66e-5 | 3.01e-3 ✓ sig. |
| regulation of canonical Wnt signaling pathway | GO:0060828 | 2 / 37 | 91.8× | 2.07e-4 | 5.22e-3 ✓ sig. |
| adipose tissue development | GO:0060612 | 2 / 46 | 73.9× | 3.21e-4 | 7.05e-3 ✓ sig. |
| regulation of G1/S transition of mitotic cell cycle | GO:2000045 | 2 / 57 | 59.6× | 4.94e-4 | 9.41e-3 ✓ sig. |
| single stranded viral RNA replication via double stranded DNA intermediate | GO:0039692 | 1 / 1 | 1,699× | 5.89e-4 | 1.06e-2 ✓ sig. |
| response to butyrate | GO:1903544 | 1 / 1 | 1,699× | 5.89e-4 | 1.06e-2 ✓ sig. |
| epidermal growth factor receptor signaling pathway | GO:0007173 | 2 / 64 | 53.1× | 6.23e-4 | 1.10e-2 ✓ sig. |
| somatic stem cell population maintenance | GO:0035019 | 2 / 64 | 53.1× | 6.23e-4 | 1.10e-2 ✓ sig. |
| Ras protein signal transduction | GO:0007265 | 2 / 79 | 43.0× | 9.47e-4 | 1.42e-2 ✓ sig. |
| mesenchymal cell differentiation involved in kidney development | GO:0072161 | 1 / 2 | 849× | 1.18e-3 | 1.59e-2 ✓ sig. |
| response to muscle inactivity | GO:0014870 | 1 / 2 | 849× | 1.18e-3 | 1.59e-2 ✓ sig. |
| regulation of gene expression | GO:0010468 | 3 / 402 | 12.7× | 1.43e-3 | 1.79e-2 ✓ sig. |
| positive T cell selection | GO:0043368 | 1 / 3 | 566× | 1.76e-3 | 1.99e-2 ✓ sig. |